Evidence map›Paper›PMID 40772647›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Bicyclo[1.1.0]tetragermane-2,4-diide Diradicaloid.

Falk Ebeler, Yury V Vishnevskiy, Jan-Hendrik Lamm, Beate Neumann, Hans-Georg Stammler, Rajendra S Ghadwal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Bicyclo[1.1.0]tetragermane-2,4-diide Diradicaloid.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Falk EbelerMolecular Inorganic Chemistry and Catalysis, Inorganic and Structural Chemistry, Center for Molecular Materials, Faculty of Chemistry, Universität Bielefeld, Universitätsstrasse 25, D-33615, Bielefeld, Germany.ORCID https://orcid.org/0000-0002-4735-7889
Yury V VishnevskiyMolecular Inorganic Chemistry and Catalysis, Inorganic and Structural Chemistry, Center for Molecular Materials, Faculty of Chemistry, Universität Bielefeld, Universitätsstrasse 25, D-33615, Bielefeld, Germany.ORCID https://orcid.org/0000-0002-7130-6280
Jan-Hendrik LammMolecular Inorganic Chemistry and Catalysis, Inorganic and Structural Chemistry, Center for Molecular Materials, Faculty of Chemistry, Universität Bielefeld, Universitätsstrasse 25, D-33615, Bielefeld, Germany.ORCID https://orcid.org/0000-0002-1485-757X
Beate NeumannMolecular Inorganic Chemistry and Catalysis, Inorganic and Structural Chemistry, Center for Molecular Materials, Faculty of Chemistry, Universität Bielefeld, Universitätsstrasse 25, D-33615, Bielefeld, Germany.
Hans-Georg StammlerMolecular Inorganic Chemistry and Catalysis, Inorganic and Structural Chemistry, Center for Molecular Materials, Faculty of Chemistry, Universität Bielefeld, Universitätsstrasse 25, D-33615, Bielefeld, Germany.
Rajendra S GhadwalMolecular Inorganic Chemistry and Catalysis, Inorganic and Structural Chemistry, Center for Molecular Materials, Faculty of Chemistry, Universität Bielefeld, Universitätsstrasse 25, D-33615, Bielefeld, Germany.ORCID https://orcid.org/0000-0003-2146-5432

Funding

Deutsche Forschungsgemeinschaft 243500032Deutsche Forschungsgemeinschaft 466111525Deutsche Forschungsgemeinschaft 514566227Deutsche Forschungsgemeinschaft 549520861
6 · The paper itself

Abstract

The synthesis, structure, and reactivity of the bicyclo[1.1.0]tetragermane-2,4-diide compound [(ADC)Ge

Indexed as

CarbeneClusterDiradicaloidGermaniumMain groupStretched bond

Identifiers

PMID40772647
PMCPMC12435412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.